missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ERGIC3 (aa 156-228) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (99%), Rat (99%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-53289 (PA5-53289. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
ERGIC3 is possible role in transport between endoplasmic reticulum and Golgi.
Specifications
Specifications
| Accession Number | Q9Y282 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 51614 |
| Name | Human ERGIC3 (aa 156-228) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 2310015B14Rik; AV318804; C20orf47; CGI-54; D2Ucla1; dJ477O4.2; Endoplasmic reticulum-Golgi intermediate compartment protein 3; endoplasmic reticulum-localized protein ERp43; ERGIC and golgi 3; ERGIC3; ERV46; NY-BR-84; PRO0989; Sdbcag84; serologically defined breast cancer antigen 84; serologically defined breast cancer antigen NY-BR-84; Serologically defined breast cancer antigen NY-BR-84 homolog |
| Common Name | ERGIC3 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction